Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1
Active, not recruiting · NCT06222827 · Registry updated 2025-03-26Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Study to Evaluate the Efficacy and Safety of Satralizumab in FSHD1 | facioscapulohumeral muscular dystrophy 1 | Active, not recruiting | Phase 2 | 2025-03-26 | NCT06222827 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Centre Hospitalier Universitaire de Nice | 229 |
2 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| CHEO Research Institute Ottawa | Ottawa | Canada | 1 |
| CHU de Nice | Nice | France | 17 |